Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Valneva

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial.
BACKGROUND Chikungunya disease, which results in incapacitating arthralgia, has been reported worldwide. We developed a live… Expand
Is this relevant?
2019
2019
Comparison of the immunogenicity of Dukoral® oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate - A controlled trial.
BACKGROUND The evidence for recommendations regarding vaccination in solid organ transplant recipients is sparse. There is little… Expand
Is this relevant?
2018
2018
Despite antibiotic treatment of travellers' diarrhoea, pathogens are found in stools from half of travellers at return.
BACKGROUND Among visitors to the (sub)tropics, 20-50% contract travellers' diarrhoea (TD) and 5-30% take antibiotics. While… Expand
  • figure 1
  • table 1
  • table 3
Is this relevant?
2017
2017
Patients hospitalized abroad as importers of multiresistant bacteria-a cross-sectional study.
OBJECTIVES The pandemic spread of multidrug-resistant (MDR) bacteria poses a threat to healthcare worldwide, with highest… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2017
2017
Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - Data of a prospective traveller study.
BACKGROUND One third of travellers to the poor regions of the (sub)tropics become colonized by extended-spectrum beta-lactamase… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2017
2017
Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region
Background: Japanese encephalitis (JE) is a major public health concern in Asia and poses a small but potentially fatal threat to… Expand
Is this relevant?
2017
2017
Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children: An Open-label, Randomized, Active-controlled, Phase 3 Study
Background: Japanese encephalitis remains a serious health concern in Asian countries and has sporadically affected pediatric… Expand
Is this relevant?
2017
2017
Cardiovascular Scoring and Age-Related Mutations Predict the Occurrence of Adverse Vascular Events in CML Patients during Nilotinib Therapy
Although otherwise considered a relatively safe drug, the BCR/ABL1 tyrosine kinase inhibitor nilotinib has recently been… Expand
Is this relevant?
2015
2015
Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
BACKGROUND Japanese Encephalitis (JE) virus occurs in wide regions of Asia with over 3 billion people living in areas at risk for… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4
Is this relevant?
2015
2015
Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine.
BACKGROUND For individuals traveling at short notice to rabies and Japanese encephalitis (JE) endemic countries, concomitant… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE